The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials

S. Cascinu, D. Poli, A. Zaniboni, S. Lonardi, R. Labianca, A. Sobrero, G. Rosati, M. Di Bartolomeo, M. Scartozzi, V. Zagonel, N. Pella, M. Banzi, V. Torri

Research output: Contribution to journalArticle

Cite this